S&P 500 Financials Sector SEC Filings — February 12, 2026

13-02-2026

TRIO-TECH INTERNATIONAL filed a Form 8-K on February 13, 2026 (AccNo: 0001437749-26-004011), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided information. This is a standard voluntary earnings-related filing with no quantitative data available for analysis.

13-02-2026

COLUMBIA BANKING SYSTEM, INC. filed an 8-K on February 13, 2026 (AccNo: 0000887343-26-000039, Size: 217 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing metadata. This is a multi-item filing with no quantitative metrics, comparisons, or directional indicators provided.

13-02-2026

Moderna, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001682852-26-000015), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators were mentioned.

• ·AccNo: 0001682852-26-000015
• ·Sector: not specified

13-02-2026

Lendway, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-014713), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative details were provided in the filing description. This appears to be a standard earnings-related disclosure without detailed performance data.

13-02-2026

Immunic, Inc. filed a Form 8-K on 2026-02-13 disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, share counts, or financial metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative data for impact assessment.

13-02-2026

Sensient Technologies Corp filed an 8-K on February 13, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases, but specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided information. No positive or negative performance indicators are detailed.

13-02-2026

13-02-2026

Cooper-Standard Holdings Inc. filed an 8-K on 2026-02-13 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing focused on financial results announcement. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.

13-02-2026

Synchronoss Technologies Inc filed an 8-K on 2026-02-13 disclosing the termination of a material definitive agreement (Item 1.02) and completion of an acquisition or disposition of assets (Item 2.01), alongside notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures or elections of directors and officers (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative financial metrics, deal values, parties involved, or specific transaction terms were disclosed. These events indicate major corporate restructuring with no offsetting positive metrics provided.

13-02-2026

Newell Brands Inc. filed a Form 8-K on 2026-02-13 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

13-02-2026

AMC Entertainment Holdings, Inc. filed an 8-K on 2026-02-13 under Item 1.01 disclosing entry into a Material Definitive Agreement and under Item 9.01 providing Financial Statements and Exhibits. No specific details, transaction values, financial metrics, parties involved, or impacts are disclosed in the provided filing summary. No quantitative data or period-over-period comparisons are mentioned.

13-02-2026

Haymaker Acquisition Corp. 4 filed an SEC document on February 13, 2026 (AccNo: 0001104659-26-014575, size 13 MB) related to a Merger/Acquisition event. No specific details on deal structure, parties involved beyond the filer, valuation, consideration, strategic rationale, regulatory pathway, shareholder impact, or market implications are explicitly stated or disclosed in the provided metadata. Critical transaction terms, financial metrics, and quantitative data are entirely absent.

• ·Filing Accession Number: 0001104659-26-014575
• ·Filing Size: 13 MB
• ·Sector: not specified

13-02-2026

Marcus & Millichap, Inc. filed an 8-K on February 13, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.

13-02-2026

Vyome Holdings, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-015795, Size: 33 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are explicitly stated.

13-02-2026

Carlyle Secured Lending, Inc. filed an 8-K on February 13, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, financial metrics, transaction values, or performance changes disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance revisions are mentioned.

• ·AccNo: 0001544206-26-000006
• ·File size: 190 KB
• ·Critical missing information: Full content of Regulation FD disclosure, exhibit details, any financial data, transaction specifics, or scheduled events - affects analysis quality

13-02-2026

W. P. Carey Inc. filed a Form 8-K on 2026-02-13 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction values, financial metrics, or impacts disclosed in the provided information. No positive or negative metrics are mentioned.

13-02-2026

ALLIANCE ENTERTAINMENT HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006492), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, position, appointment or resignation status, reasons, and timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

13-02-2026

Nektar Therapeutics filed a Form 8-K on 2026-02-13 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on a material agreement and additional events, with exhibits attached. No financial metrics, transaction details, positive or negative impacts, or quantitative data are disclosed.

13-02-2026

Sound Financial Bancorp, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with limited transparency on content.

13-02-2026

AZZ INC filed an 8-K on February 13, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, period-over-period comparisons, or quantitative data are disclosed in the filing summary. The disclosure appears informational with attached exhibits, but content details are not provided.

13-02-2026

SunHydrogen, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-015747, Size: 380 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or quantitative data provided.

13-02-2026

News Corp filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are provided.

13-02-2026

Hyperscale Data, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001214659-26-001643, Size: 286 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure, financial metrics, transactions, or other quantitative data are provided in the filing summary. This is a multi-item voluntary disclosure with no mentioned positive or negative metrics.

13-02-2026

Rithm Property Trust Inc. filed an 8-K on February 13, 2026, under Item 2.02 reporting Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or guidance are disclosed in the provided filing details. This is an informational disclosure of financial results with exhibits attached.

13-02-2026

Nukkleus Inc. filed an 8-K on February 13, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. No positive or negative metrics are mentioned.

13-02-2026

Atmus Filtration Technologies Inc. filed an 8-K on 2026-02-13 under Item 2.02 disclosing Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, positive or negative performance indicators, or other quantitative details are mentioned in the filing. Sector is not specified.

• ·AccNo: 0001921963-26-000012
• ·File Size: 492 KB

13-02-2026

Advance Auto Parts Inc filed an 8-K on February 13, 2026, reporting under Item 2.02 results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing summary. No period-over-period comparisons, positive or negative changes, or quantitative data are available.

13-02-2026

Farmer Brothers Co filed an 8-K on February 13, 2026 (AccNo: 0000034563-26-000012), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantified positive or negative impacts mentioned.

13-02-2026

CERO Therapeutics Holdings, Inc. filed a Form 8-K on February 13, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 4.01 (Changes in Registrant's Certifying Accountant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, named parties, or quantitative impacts are disclosed in the provided filing summary. This multi-item filing signals several operational and financial changes, but lacks details to assess directional impact.

13-02-2026

Wendy's Co filed a Form 8-K on February 13, 2026 (AccNo: 0001193125-26-049816), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard disclosure for financial results with attached exhibits, but specific revenue, earnings, margins, or other metrics are NOT_DISCLOSED in the provided information. No period-over-period comparisons, guidance, or other quantitative details are available.

13-02-2026

Enbridge Inc filed an 8-K on February 13, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, transaction details, or scheduled events are mentioned.

13-02-2026

DraftKings Inc. filed a Form 8-K on February 13, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no detailed operational results available.

13-02-2026

13-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 13, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material non-public information with attached exhibits.

13-02-2026

Tri Pointe Homes, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific quantitative details, transaction sizes, financial impacts, or directional metrics disclosed. No positive or negative performance metrics are provided.

13-02-2026

Noodles & Co filed a Form 8-K on February 13, 2026, under Item 3.03 disclosing material modifications to rights of security holders, Item 5.03 reporting amendments to articles of incorporation or bylaws or a change in fiscal year, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. This is a multi-item filing with no quantitative financial metrics, transaction details, or performance comparisons provided. No positive or negative impacts are quantified in the available information.

13-02-2026

BRAINSTORM CELL THERAPEUTICS INC. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015262), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing signals a potentially significant financing or partnership event typical in biotech but lacks specifics on terms or effects.

• ·Filing Accession Number: 0001104659-26-015262
• ·File Size: 730 KB
• ·Multi-item mandatory 8-K filing

13-02-2026

13-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on February 13, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided information. This appears to be a standard earnings-related disclosure with exhibits attached.

13-02-2026

Bloomin' Brands, Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer's name, position, reason for change, or timing are disclosed.

13-02-2026

Strive, Inc. filed a Form 8-K on February 13, 2026, under Item 8.01 Other Events, indicating a material event not covered by other specific 8-K items. No details on the core event, financial metrics, transaction values, or quantitative data were explicitly stated in the provided filing information. No positive or negative metrics were disclosed.

13-02-2026

Sonic Automotive Inc filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-007898) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed. This is a standard governance filing with no financial metrics, performance data, or scheduled events mentioned.

13-02-2026

LCI Industries filed an 8-K on February 13, 2026 (AccNo: 0000763744-26-000004, size 705 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.

• ·Event date: February 13, 2026
• ·Source: us_sec
• ·Sector: not specified

13-02-2026

13-02-2026

Evommune, Inc. filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), alongside Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). While the material agreement signals potential strategic advancement, the equity sales raise dilution concerns. No specific transaction values, terms, financial impacts, or quantitative details are disclosed.

13-02-2026

AtlasClear Holdings, Inc. filed an 8-K on February 13, 2026, under Item 2.02 to disclose results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific financial metrics, performance comparisons, guidance, or quantitative details are disclosed in the filing summary.

13-02-2026

GENCO SHIPPING & TRADING LTD filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, names, reasons, or timing were disclosed.

13-02-2026

HCW Biologics Inc. filed an 8-K on February 13, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01 and providing Financial Statements and Exhibits under Item 9.01. No details on the agreement's parties, terms, value, strategic rationale, or financial impacts are mentioned. This is a multi-item mandatory filing with no quantitative metrics, positive or negative changes, or performance comparisons provided.

13-02-2026

ASTROTECH Corp filed an 8-K on February 13, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing summary. This represents a standard voluntary disclosure of financial results without directional performance indicators.

13-02-2026

Citius Oncology, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-015894), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results.

13-02-2026

PCS Edventures!, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material nonpublic information with attached exhibits. No quantitative financial metrics, transactions, period-over-period changes, positive or negative performance indicators, or other specific details are disclosed.

13-02-2026

Royal Caribbean Cruises Ltd filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-014730), reporting under Item 1.01 entry into a material definitive agreement and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed. This appears to be a multi-item mandatory filing with limited public summary information available.

• ·Filing size: 482 KB
• ·Sector: not specified

13-02-2026

LAS VEGAS SANDS CORP filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. Sector is not specified.

13-02-2026

Citius Pharmaceuticals, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001213900-26-015895), disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and under Item 2.02 results of operations and financial condition. Item 9.01 references financial statements and exhibits. This multi-item filing highlights a material compliance failure with exchange listing requirements, with no specific financial metrics or performance details provided.

• ·Multi-item 8-K filing (Items 2.02, 3.01, 9.01)
• ·Event date aligns with filing date: 2026-02-13

13-02-2026

Visa Inc. filed an 8-K on February 13, 2026, under Item 7.01 Regulation FD Disclosure. This is a voluntary disclosure likely sharing previously provided material nonpublic information publicly. No financial metrics, transactions, events, or other quantitative details are explicitly stated in the filing information provided.

13-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-13 under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are disclosed in the provided information. This is a multi-item mandatory filing likely made timely on the event date.

13-02-2026

NATIONAL HEALTHCARE CORP filed an 8-K on February 13, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or directional impacts are mentioned.

13-02-2026

Bogota Financial Corp. filed a Form 8-K on 2026-02-13 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a standard voluntary disclosure for financial results. No specific quantitative metrics, period-over-period changes, or other details are provided in the filing summary.

13-02-2026

Rockwell Automation, Inc. filed a Form 8-K on February 13, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This discloses the results of matters submitted to shareholders at a meeting, but no specific proposals, vote counts, outcomes, or other details are provided. No financial metrics, changes, or impacts are mentioned.

13-02-2026

PLUG POWER INC filed an 8-K on February 13, 2026, disclosing amendments to its Articles of Incorporation or Bylaws under Item 5.03 and submission of matters to a vote of security holders under Item 5.07. Item 9.01 includes financial statements and exhibits. No quantitative details, vote outcomes, amendment specifics, or financial impacts are disclosed in the filing summary.

13-02-2026

CBL & Associates Properties Inc filed an 8-K on February 13, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance were mentioned in the filing description. This is a standard earnings-related disclosure without quantified metrics provided.

13-02-2026

Louisiana-Pacific Corp filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantitative metrics, transaction details, or performance comparisons mentioned.

13-02-2026

Track Group, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001437749-26-004020), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

13-02-2026

UFP Industries Inc filed a Form 8-K on February 13, 2026 (AccNo: 0000912767-26-000004, Size: 169 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or contents of the exhibits disclosed. No financial metrics, transactions, or impacts are mentioned.

13-02-2026

Norris Industries, Inc. filed an 8-K on February 13, 2026, disclosing a change in its certifying accountant under Item 4.01. The filing also references financial statements and exhibits under Item 9.01. No specific details, financial metrics, reasons for the change, or quantitative data were disclosed.

13-02-2026

13-02-2026

SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed an 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or other outcomes are mentioned.

13-02-2026

Graco Inc filed a Form 8-K on February 13, 2026 (AccNo: 0000042888-26-000036, size 141 KB), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, reasons for the change, effective dates, or any quantitative terms are explicitly stated. This represents a standard officer change event with sector not specified and no associated financial metrics or performance comparisons provided.

• ·AccNo: 0000042888-26-000036
• ·Event Type: Officer Change
• ·Source: us_sec

13-02-2026

Wells Fargo & Company/MN filed a Form 8-K on February 13, 2026 (AccNo: 0001839882-26-009703, Size: 1 MB), reporting solely under Item 9.01 Financial Statements and Exhibits. No specific financial statements, exhibits, transactions, metrics, or events are detailed in the provided filing information. Critical details remain NOT_DISCLOSED, limiting assessment of any material impact.

13-02-2026

Mag Magna Corp filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. Sector information is not specified.

13-02-2026

CSP Inc. (/MA/) filed an 8-K on February 13, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as director elections or other proposals. No specific details on the matters voted upon, vote outcomes, attendance, or any quantitative results are disclosed. This is a single-item filing with no financial metrics, changes, or other data provided.

13-02-2026

Figure Technology Solutions, Inc. filed a Form 8-K on February 13, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing summary. Sector information is not specified.

13-02-2026

MOVING iMAGE TECHNOLOGIES INC. filed an 8-K on February 13, 2026 (AccNo: 0001437749-26-004067, Size: 307 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were disclosed in the filing metadata. This is a multi-item voluntary disclosure typical for earnings releases.

13-02-2026

Columbus Circle Capital Corp II filed a Form 8-K on February 13, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This multi-item filing signals several corporate developments but lacks data for directional assessment.

13-02-2026

Immersion Corp filed a Form 8-K on 2026-02-13 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transaction values, or other quantitative details are disclosed.

13-02-2026

Carlyle Credit Income Fund filed a Form 8-K on February 13, 2026, under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, metrics, or transactions are disclosed in the filing summary provided.

13-02-2026

Star Equity Holdings, Inc. filed an 8-K on February 13, 2026, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial statements, exhibits, transactions, or metrics are provided in the filing summary. Critical content of the disclosure is missing, limiting assessment of impact.

• ·Filing Accession Number: 0001210708-26-000022
• ·Filing size: 256 KB

13-02-2026

NETSTREIT Corp. filed a Form 8-K on February 13, 2026 (AccNo: 0001104659-26-015200, size 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed. This appears to be a voluntary informational disclosure with no quantified positive or negative impacts provided.

13-02-2026

Olympic Steel Inc. filed an 8-K on February 13, 2026, reporting the termination of a material definitive agreement (Item 1.02) and the completion of an acquisition or disposition of assets (Item 2.01), alongside changes in control of the registrant (Item 5.01). The filing also discloses notice of delisting or failure to satisfy listing standards with transfer of listing (Item 3.01), material modifications to rights of security holders (Item 3.03), departure/election of directors and officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). No quantitative financial metrics, deal values, parties involved, or performance comparisons were disclosed.

13-02-2026

AMES NATIONAL CORP filed an 8-K on February 13, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, period-over-period comparisons, or directional data (positive, negative, or flat) are disclosed in the provided filing information. This is a multi-item informational filing with no detailed content available.

13-02-2026

Axon Enterprise, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing information.

13-02-2026

OS Therapies Inc filed an 8-K on February 13, 2026, reporting under Item 8.01: Other Events. No specific details regarding the core event, financial impacts, transaction values, or quantitative metrics are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative performance metrics.

13-02-2026

POOL CORP filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051351), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including affected positions, names, reasons for the change, internal/external status, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

13-02-2026

SLM Corp filed an 8-K on February 13, 2026, reporting under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information to ensure fair disclosure compliance. Item 9.01 lists Financial Statements and Exhibits, but specific contents, metrics, or events are NOT_DISCLOSED. No quantitative financial data, comparisons, or directional impacts are provided in the filing summary.

13-02-2026

Exodus Movement, Inc. filed an 8-K on February 13, 2026, under Item 5.08 disclosing shareholder nominations pursuant to Exchange Act Rule 14a-11 and under Item 8.01 reporting other events. No financial metrics, transaction values, or quantitative impacts are disclosed in the filing summary. This is an informational filing with no positive or negative performance metrics provided.

13-02-2026

Exact Sciences Corp filed a Form 8-K on February 13, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed operational or balance sheet impacts provided.

13-02-2026

MONRO, INC. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051342), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses unspecified other events with attached financial statements or exhibits. No quantitative metrics, transaction details, period-over-period comparisons, or named entities beyond the filer are mentioned.

13-02-2026

FOX FACTORY HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001424929-26-000004), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on affected positions, individuals involved, reasons for change, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

Tennant Co filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial metrics provided. No positive or negative quantitative impacts, guidance changes, or operational metrics were disclosed.

13-02-2026

HECLA MINING CO/DE/ filed an 8-K on February 13, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, or operational details are disclosed in the filing metadata. Critical content of the disclosure is missing, limiting analysis.

13-02-2026

AIR T INC filed an 8-K on February 13, 2026 (AccNo: 0000353184-26-000017, Size: 2 MB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This is a standard voluntary disclosure of financial results with no quantitative metrics available for analysis.

13-02-2026

Marpai, Inc. filed an 8-K on 2026-02-13 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 includes Financial Statements and Exhibits. No quantitative details, transaction specifics, parties, dollar values, or impacts are disclosed.

13-02-2026

Aimei Health Technology Co., Ltd. filed an 8-K on February 13, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, terms, or financial metrics are disclosed.

13-02-2026

BiomX Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

13-02-2026

LendingTree, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or timing are disclosed. No financial metrics, quantitative data, or other outcomes such as board decisions are mentioned.

13-02-2026

Roadzen Inc. filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006696, Size: 619 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the filing description. This is a standard earnings-related disclosure with no directional performance data available.

13-02-2026

NEXTNRG, INC. filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no period-over-period comparisons or other numerical data available.

13-02-2026

Texas Roadhouse, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

13-02-2026

Offerpad Solutions Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051334), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed.

13-02-2026

Bayview Acquisition Corp filed an 8-K on February 13, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details such as amounts, terms, parties involved, or connection to any merger/acquisition are provided in the filing summary. Sector is not specified.

13-02-2026

GEE Group Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001477932-26-000817), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a voluntary disclosure of financial results with attached exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance were disclosed in the provided filing information.

13-02-2026

Ryerson Holding Corp filed an 8-K on February 13, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation (Item 2.03), departure or election of directors/officers or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, values, metrics, or impacts are disclosed.

13-02-2026

e.l.f. Beauty, Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individuals involved, reason for change, or any financial impacts are provided. No quantitative metrics, performance data, or scheduled events mentioned.

13-02-2026

Healthcare Triangle, Inc. filed an 8-K on February 13, 2026, disclosing events under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transaction values, or directional impacts are provided in the filing summary. This appears to be a multi-item mandatory filing with no quantified positive or negative changes disclosed.

13-02-2026

SpyGlass Pharma, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are provided in the available information. No positive or negative impacts, quantitative data, or further context such as board composition changes are disclosed.

13-02-2026

Spring Valley Acquisition Corp. IV filed an 8-K on 2026-02-13 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No quantitative deal terms, financial metrics, parties involved beyond the filer, or performance comparisons were disclosed. This filing signals a likely SPAC de-SPAC merger but lacks specifics for impact assessment.

13-02-2026

Society Pass Incorporated filed an 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments, but lacks context for directional assessment.

13-02-2026

Inmune Bio, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001213900-26-016385, Size: 291 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, or quantitative data are disclosed in the filing summary. This appears to be a multi-item voluntary disclosure likely including a press release or update as an exhibit.

13-02-2026

Varex Imaging Corp filed a Form 8-K on February 13, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific proposals, vote outcomes, numerical results, or other metrics are disclosed in the filing information provided. This is a standard informational disclosure following a shareholder meeting.

13-02-2026

PLUS Therapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051379) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, or terms are disclosed. No quantitative metrics, financial impacts, or other changes are mentioned.

13-02-2026

Jet.AI Inc. filed a multi-item Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006713), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, or impacts are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

• ·Multi-item 8-K filing indicating multiple corporate actions
• ·Filing size: 882 KB

13-02-2026

Intensity Therapeutics, Inc. filed a Form 8-K on February 13, 2026, reporting multiple items: Item 3.03 on material modifications to rights of security holders, Item 5.03 on amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 on other events, and Item 9.01 on financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative changes, or numerical data are disclosed in the provided filing summary. This is a multi-item informational filing with no disclosed impacts on revenue, earnings, balance sheet, or guidance.

13-02-2026

Cambridge Acquisition Corp. filed an 8-K on 2026-02-13 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), related to a merger/acquisition event. No deal structure, valuation, parties, strategic rationale, financial metrics, or other quantitative details are disclosed in the provided filing information. No positive or negative metrics reported.

13-02-2026

Live Oak Bancshares, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details such as officer names, positions affected, appointment or resignation status, reasons, or quantitative data are disclosed.

13-02-2026

Centessa Pharmaceuticals plc filed an 8-K on 2026-02-13 (AccNo: 0001193125-26-051424, Size: 189 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key position affected (e.g., CEO, CFO), appointment or resignation status, reasons, timing, or any financial metrics are disclosed. No positive or negative governance implications can be assessed due to lack of details.

• ·AccNo: 0001193125-26-051424
• ·Filing size: 189 KB
• ·Sector: not specified

13-02-2026

Beyond Air, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006708), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are provided in the filing description. No positive, negative, or flat performance indicators are mentioned.

13-02-2026

Huntsman Corp filed a Form 8-K on February 13, 2026, reporting entry into a new material definitive agreement under Item 1.01 while simultaneously disclosing termination of a prior material definitive agreement under Item 1.02; however, it also announced creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 provides financial statements and exhibits. This multi-item filing signals significant contractual and financial changes, but no specific details, dollar values, or impacts are disclosed.

13-02-2026

Gran Tierra Energy Inc. filed a Form 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure.

13-02-2026

Apple Hospitality REIT, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or timing are provided in the filing summary. No quantitative data, performance metrics, or further governance implications are disclosed.

13-02-2026

MID AMERICA APARTMENT COMMUNITIES INC. filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. This appears to be an informational disclosure without quantified financial metrics or directional impacts provided.

13-02-2026

Myseum, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001213900-26-016420), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), with a filing size of 270 KB. No specific details on the nature of the other events, transaction values, financial metrics, or exhibit contents are disclosed. This is a multi-item voluntary filing signaling potentially material information, but critical content is NOT_DISCLOSED.

• ·Filing size: 270 KB
• ·Accession Number: 0001213900-26-016420

13-02-2026

Inception Growth Acquisition Ltd filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016421, Size: 263 KB), disclosing other events under Item 8.01, likely related to a merger/acquisition. Item 9.01 includes financial statements and exhibits. No specific deal structure, financial metrics, parties involved, or quantitative data are explicitly stated.

• ·AccNo: 0001213900-26-016421
• ·Sector: NOT_DISCLOSED

13-02-2026

TransDigm Group Inc filed an 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction values, financial impacts, or other quantitative details are disclosed.

13-02-2026

Westwood Holdings Group Inc filed an 8-K on February 13, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other quantitative metrics. No positive or negative performance indicators, guidance, or scheduled events are detailed in the filing information.

13-02-2026

Emerson Electric Co filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

13-02-2026

SAGA COMMUNICATIONS INC filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's name, title, reason for change, timing, or any quantitative metrics are disclosed.

13-02-2026

Datavault AI Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001104659-26-015215, Size: 351 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial metrics, or exhibits disclosed in the provided filing summary. No quantitative data, guidance, or scheduled events are mentioned.

13-02-2026

Envirotech Vehicles, Inc. filed an 8-K on February 13, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 8.01 discloses other events. No financial metrics, quantitative data, or period-over-period comparisons provided.

13-02-2026

Data Storage Corp filed an 8-K on February 13, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for changes, or any quantitative metrics are disclosed.

13-02-2026

Disc Medicine, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001193125-26-051504, Size: 307 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, financial metrics, or impacts disclosed in the provided information. No quantitative data, comparisons, or scheduled events are mentioned.

13-02-2026

Martin Marietta Materials Inc filed an 8-K on February 13, 2026, disclosing under Item 1.04 mine safety matters involving reporting of shutdowns and patterns of violations. No additional quantitative details, financial impacts, or operational specifics were provided in the filing summary.

13-02-2026

Werewolf Therapeutics, Inc. filed an 8-K on February 13, 2026, disclosing costs associated with exit or disposal activities under Item 2.05, officer or director changes including departures, elections, appointments, or compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. No specific details on personnel changes, reasons, costs, or financial impacts are disclosed. This combination signals potential restructuring but lacks quantification for assessment.

13-02-2026

NORTHROP GRUMMAN CORP /DE/ filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008140), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected officer, position, action (appointment or resignation), reason, effective date, or any quantitative data are disclosed.

• ·Event Type: Officer Change
• ·Source: us_sec
• ·Sector: not specified
• ·Filing Size: 190 KB

13-02-2026

QuidelOrtho Corp filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051461), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected officer, position, reason for change, or timing are disclosed. Sector is not specified.

• ·Filing size: 130 KB

13-02-2026

Knight-Swift Transportation Holdings Inc. filed an 8-K on February 13, 2026 (AccNo: 0001492691-26-000012), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or scheduled events mentioned.

13-02-2026

SWK Holdings Corp filed a Form 8-K on February 13, 2026, under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. No quantitative details such as dollar value, terms, parties, or financial impact are provided. This is a single-item mandatory disclosure signaling a material financial commitment.

13-02-2026

Cycurion, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001628280-26-008157, size: 217 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events or exhibits disclosed in the provided information. No financial metrics, transactions, or quantitative data are mentioned.

13-02-2026

Cencora, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This multi-item filing indicates significant corporate actions but provides no quantitative details on transaction size, financial impacts, or strategic context. No positive or negative metrics are disclosed.

13-02-2026

Copper Property CTL Pass Through Trust filed a Form 8-K on 2026-02-13 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving voluntary disclosure of potentially material information to comply with Regulation FD, accompanied by exhibits. No specific details, financial metrics, transactions, or directional impacts are disclosed in the provided filing summary.

• ·AccNo: 0001837671-26-000013
• ·File Size: 163 KB

13-02-2026

CNL Healthcare Properties, Inc. filed a Form 8-K on February 13, 2026, under Item 8.01 reporting Other Events. No specific details of the event, quantitative metrics, financial impacts, or period-over-period comparisons are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

13-02-2026

Nuvve Holding Corp. filed an 8-K on February 13, 2026, reporting under Item 1.02 the termination of a material definitive agreement, which represents a negative development. Item 9.01 discloses financial statements and exhibits. No quantitative financial impacts, transaction values, or strategic details are provided.

13-02-2026

Phoenix Education Partners, Inc. filed an 8-K on February 13, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters voted upon, meeting date, vote results, or any quantitative outcomes are disclosed. This is a single-item mandatory disclosure with no financial metrics or directional implications provided.

13-02-2026

Ascend Wellness Holdings, Inc. filed an 8-K on February 13, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. No positive, negative, or flat metrics are mentioned.

13-02-2026

Lithia Motors Inc filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with Item 9.01 for Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other changes are mentioned.

13-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included, but specific details such as names, titles, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

13-02-2026

MVB Financial Corp filed an 8-K on February 13, 2026 (AccNo: 0001277902-26-000013, Size: 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material non-public information with attached exhibits. No specific transaction details, financial metrics, or quantitative data are disclosed in the filing summary.

13-02-2026

Idea Acquisition Corp. filed an 8-K on 2026-02-13 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections/appointments of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. All quantitative and qualitative transaction specifics are NOT_DISCLOSED.

13-02-2026

Eventbrite, Inc. filed a Form 8-K on February 13, 2026, reporting solely under Item 8.01 Other Events. No specific details of the event, quantitative metrics, transactions, or directional implications are disclosed in the provided filing information. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.

13-02-2026

Red Robin Gourmet Burgers Inc filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, terms, dollar value, or financial impacts are disclosed. No quantitative metrics, period-over-period comparisons, positive or negative changes, or operational data are provided in the filing summary.

13-02-2026

Edesa Biotech, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001171843-26-000810), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were provided in the filing description. This appears to be a voluntary earnings-related disclosure with limited accessible details for analysis.

13-02-2026

GCI Liberty, Inc. filed an 8-K on February 13, 2026, under Item 5.04 disclosing a temporary suspension of trading under the registrant's employee benefit plans. Item 9.01 reports financial statements and exhibits, but no specific details, financial metrics, or quantitative impacts are provided. This is an informational filing with no disclosed positive or negative performance metrics.

13-02-2026

Peraso Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016466), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions affected, reasons for change, or quantitative details are disclosed.

• ·File size: 189 KB

13-02-2026

Iveda Solutions, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006726), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, dollar values, or financial impacts disclosed in the provided summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

13-02-2026

FG Nexus Inc. filed an 8-K on February 13, 2026, disclosing under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits. No financial metrics, transaction details, or directional impacts are specified.

13-02-2026

SmartKem, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001104659-26-015258), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This indicates the company has been notified by its exchange of non-compliance with listing requirements. No financial metrics, transaction values, or additional details such as reasons for the notice or impacts were disclosed.

13-02-2026

United Acquisition Corp. I filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006747), disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on deal structure, parties involved, valuation, transaction terms, synergies, regulatory pathway, or shareholder impacts are provided in the filing summary. All quantitative metrics, including transaction value and share counts, are NOT_DISCLOSED.

13-02-2026

Sysco Corp filed an 8-K on 2026-02-13 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or obligation under an off-balance sheet arrangement under Item 2.03, with financial statements and exhibits provided under Item 9.01. No quantitative details such as transaction value, financial terms, or impacts on revenue, earnings, or balance sheet are disclosed. This is a multi-item mandatory disclosure of material events.

13-02-2026

Quetta Acquisition Corp filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006730, Size: 256 KB) disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific names, dates, details, financial metrics, or transaction information are mentioned in the filing summary. Sector not specified, and no merger/acquisition details provided.

13-02-2026

Goldman Sachs Group Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or impacts are disclosed. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

Cohen & Co Inc. filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events. No specific details on the event, financial metrics, transactions, or quantitative impacts are disclosed in the filing information provided.

13-02-2026

AMERICAN STATES WATER CO filed a Form 8-K on February 13, 2026 (AccNo: 0001628280-26-008178), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are provided in the filing summary. No quantitative data, financial metrics, or further governance implications are disclosed.

13-02-2026

Longeveron Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

13-02-2026

Ondas Holdings Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001213900-26-016523), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the 'Other Events', financial statements, exhibits, transaction values, metrics, or impacts—positive, negative, or flat—are disclosed in the provided filing summary. This is an informational filing with no quantifiable data available.

13-02-2026

Transact Technologies Inc filed an 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

13-02-2026

Bank of America Corp /DE/ filed an 8-K on February 13, 2026, under Item 8.01 Other Events (Accession No. 0000070858-26-000088, size 352 KB). No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing information. This is a single-item filing reporting other material events not covered by standard 8-K items.

13-02-2026

Profusa, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016496), reporting entry into a material definitive agreement under Item 1.01 and other events under Item 8.01. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other events are provided.

13-02-2026

Kontoor Brands, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001760965-26-000006), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment/resignation status, reasons, or any quantitative impacts are NOT_DISCLOSED.

13-02-2026

Phoenix Energy One, LLC filed a Form 8-K on February 13, 2026 (AccNo: 0001193125-26-051726), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No specific terms, dollar values, strategic details, or financial impacts of the agreement are disclosed in the provided filing summary.

13-02-2026

Sonida Senior Living, Inc. filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing summary. This is a multi-item filing with no quantitative metrics, transaction details, or performance comparisons provided.

13-02-2026

HELIX ENERGY SOLUTIONS GROUP INC filed an 8-K on 2026-02-13 disclosing entry into a Material Definitive Agreement under Item 1.01, accompanied by Financial Statements and Exhibits under Item 9.01. No specific transaction details, dollar values, financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed in the provided filing summary.

13-02-2026

CoStar Group, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or terms are disclosed.

13-02-2026

NexMetals Mining Corp. filed an 8-K on 2026-02-13 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

FLYEXCLUSIVE INC. filed a Form 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This represents a multi-item mandatory filing with no specific details provided on the agreement's nature, parties, terms, value, or impacts. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Sector: not specified

13-02-2026

NutriBand Inc. filed a Form 8-K on February 13, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, or other details are disclosed in the provided filing information.

13-02-2026

US Energy Corp filed an 8-K on February 13, 2026, reporting under Item 3.02 Unregistered Sales of Equity Securities. No details on transaction value, share count, parties, pricing, or exemptions were disclosed. This mandatory disclosure signals potential equity issuance but lacks quantification for impact assessment.

13-02-2026

BayFirst Financial Corp. filed an 8-K on 2026-02-13 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the individuals involved, reasons for change, timing, or impacts are disclosed.

13-02-2026

Invesco Mortgage Capital Inc. filed a Form 8-K on February 13, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, or events described in the provided information. Core event and impacts remain undisclosed.

13-02-2026

Crypto Co filed an 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No specific transaction values, share counts, financial impacts, or other quantitative details are disclosed. This is a multi-item filing with no period-over-period comparisons or guidance changes mentioned.

13-02-2026

Zenas BioPharma, Inc. filed an 8-K on 2026-02-13 disclosing officer changes under Item 5.02, including potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons for changes, financial metrics, or quantitative details are disclosed.

13-02-2026

UFP Technologies Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or financial metrics are disclosed.

13-02-2026

Timken Co filed an 8-K on February 13, 2026 (AccNo: 0000098362-26-000014) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, internal/external status, and any board composition impacts are NOT_DISCLOSED. No quantitative data, financial metrics, scheduled events, or governance implications are provided in the summary.

13-02-2026

Amkor Technology, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This filing appears informational with no directional financial or operational impacts explicitly stated.

13-02-2026

IDEXX Laboratories Inc./DE filed an 8-K on February 13, 2026 (AccNo: 0000874716-26-000007, Size: 276 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, timing, or quantitative impacts are disclosed. This is a routine governance disclosure with no financial metrics or performance data provided.

13-02-2026

Streamex Corp. filed a Form 8-K on February 13, 2026, disclosing under Item 1.02 the termination of a material definitive agreement, which signals a potentially negative development, while Item 5.02 reports departures of directors or certain officers alongside elections, appointments, and compensatory arrangements of certain officers, indicating leadership transitions. Item 8.01 covers other events and Item 9.01 includes financial statements and exhibits. This multi-item filing highlights significant corporate changes but provides no quantified financial impacts or further details.

13-02-2026

Aditxt, Inc. filed an 8-K on February 13, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific matters submitted, vote outcomes, share counts, or other numerical details are disclosed. This is an informational filing on shareholder voting activity.

13-02-2026

Criteo S.A. filed an 8-K on February 13, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial impacts, or exhibits are provided in the filing summary. No quantitative metrics, positive or negative changes, or strategic implications are mentioned.

13-02-2026

Faraday Future Intelligent Electric Inc. filed an 8-K on February 13, 2026, under Item 5.07 disclosing submission of matters to a vote of security holders, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. No specific vote outcomes, details of other events, financial metrics, or exhibit contents are disclosed. This multi-item filing provides informational updates without quantified positive or negative impacts.

13-02-2026

BRC Inc. filed a Form 8-K on 2026-02-13 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including potential transfer of listing. The filing also reports Regulation FD disclosure in Item 7.01 and attaches financial statements and exhibits in Item 9.01. No quantitative financial metrics, transaction values, or specific reasons for the delisting event are disclosed.

13-02-2026

OXBRIDGE RE HOLDINGS Ltd filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006760), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction size, parties, financial impacts, or metrics are provided in the filing summary.

13-02-2026

Delta Air Lines, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001683168-26-001033), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts were provided. Sector not specified.

13-02-2026

ATN International, Inc. filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the nature of the agreement, transaction size, financial terms, or impacts are provided in the filing summary. This multi-item filing signals potentially significant but undisclosed corporate developments.

13-02-2026

Actinium Pharmaceuticals, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, or quantitative data are disclosed. Sector information is not specified.

13-02-2026

Orchestra BioMed Holdings, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015315), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, titles, reasons for changes, timing details, compensation amounts, or other quantitative metrics are disclosed. Sector information is not specified.

13-02-2026

Charlie's Holdings, Inc. filed an 8-K on February 13, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific details on the agreement terms, transaction value, share counts, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

13-02-2026

ProPhase Labs, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006784), disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, financial exhibits, transaction values, metrics, or impacts are provided in the filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons disclosed.

13-02-2026

Envoy Medical, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period changes, or guidance were mentioned.

13-02-2026

Quantumzyme Corp. filed an 8-K on February 13, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, and under Item 9.01 listing financial statements and exhibits. No specific details on the nature of the amendments, financial impacts, quantitative metrics, or other changes are provided in the filing summary. This appears to be an informational governance update with no disclosed positive or negative financial effects.

13-02-2026

Bark, Inc. filed an 8-K on February 13, 2026, disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific details regarding the nature of the other events, contents of the exhibits, financial metrics, or transactions are provided in the filing summary. This appears to be an informational filing with no quantified positive or negative impacts disclosed.

13-02-2026

Concentrix Corp filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the nature of the financial statements and exhibits are disclosed. This appears to be a multi-item informational filing with no quantified financial or operational metrics provided.

13-02-2026

Wellgistics Health, Inc. filed a multi-item Form 8-K on February 13, 2026 (AccNo: 0001493152-26-006815, Size: 12 MB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details, transaction values, financial metrics, or impacts are disclosed in the provided filing summary. This informational filing lacks quantitative data for assessing positive or negative implications.

13-02-2026

Embecta Corp. filed an 8-K on February 13, 2026, reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the shareholder meeting matters, vote outcomes, numerical results, or other metrics are disclosed in the provided filing information. This appears to be a standard mandatory disclosure following a shareholder vote.

13-02-2026

IO Biotech, Inc. filed a Form 8-K on 2026-02-13 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event signals potential removal from a US exchange, negatively impacting stock liquidity and accessibility for US investors. No financial metrics, quantitative impacts, or additional details such as dollar values or timelines were disclosed.

13-02-2026

Banzai International, Inc. filed a Form 8-K on 2026-02-13 disclosing entry into a Material Definitive Agreement under Item 1.01, accompanied by Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, comparisons, or other data are mentioned.

13-02-2026

Fold Holdings, Inc. filed a Form 8-K on February 13, 2026, under Item 7.01 Regulation FD Disclosure, voluntarily releasing material non-public information, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents. No specific core events, transactions, financial metrics, positive or negative changes, or quantitative data are detailed in the provided filing summary. This is a multi-item informational filing with no disclosed directional implications.

13-02-2026

Funko, Inc. filed a Form 8-K on February 13, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

13-02-2026

Sensei Biotherapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051815), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.